Carey Chern serves as Executive at SCICLONE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Carey Chern has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 13, 2017 involved selling 20,708 shares valued at $231.5K.
Carey Chern currently holds 20,708 shares of SCICLONE PHARMACEUTICALS INC (SCLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carey Chern has been a net neutral trader of SCLN stock. They have purchased $0 and sold $0 worth of shares.
Carey Chern's most recent insider trade was on Oct 13, 2017, when they sold 20,708 shares at $11.18 per share.
Get notified when new Form 4 filings are submitted
| 11,274 |
| $11.18 |
| Discretionary |
| Oct 13, 2017 | SCLN | $0 | Option Exercise | 30,000 | $N/A | Discretionary |